fbpx

Eczema (Atopic Dermatitis) Study

Now Open in Kansas City

About This Research Study

Atopic dermatitis (AD), also known as eczema, is a common skin disorder. Symptoms can include flaky skin lesions and intense itching. An estimated 10% of adults and up to 20% of children suffer from AD. AD can unpredictably flare in adolescence and in adulthood.

People with moderate-to-severe AD may be eligible to join this research study of an investigational medication (ointment) for the condition. Eligible participants will receive compensation for study-related time.

Eligible participants:

  • Must be age 2 or older
  • Must have been diagnosed with chronic atopic dermatitis for at least 3 months
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you or your child.


You can talk to a Meridian enrollment specialist about this study by calling (402) 934-7563.

Expect Excellence icon - supporting research since 1999

Submit your information

Study Location

Meridian Clinical Research
8675 College Blvd, Suite 200
Overland Park, KS 66210

Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.

© 2022 MERIDIAN CLINICAL RESEARCH, LLC | Privacy Policy